Leigh M. Howard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Leigh M. Howard has a total of 174 co-authors. Here are the top co-authors by number of shared publications:
- Carlos G. Grijalva
Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee
7 shared publications Carlos G Grijalva
Department of Biomedical Informatics, Vanderbilt University Medical Center, Vanderbilt University , Nashville, Tennessee
4 shared publications- Claudio F. Lanata
Instituto de Investigación Nutricional, Lima, Peru
4 shared publications Andrew J. Spieker
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
3 shared publicationsJames D. Chappell
Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
3 shared publications- Lucie Ecker
Instituto de Investigación Nutricional, Lima, Peru
3 shared publications
Latest Publications
- 23 October 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Proportion of Colonized Person-time With Streptococcus pneumoniae and Duration of Colonization With Individual Serotypes in Young Peruvian Children
Few studies have characterized the proportion of time a child spends with nasopharyngeal pneumococcal colonization, thus at risk for pneumococcal disease. In this prospective study conducted in the early 7-valent pneumococcal conjugate vaccine implementation period, young Peruvian children exhibited pneumococcal colonization during half of the observed person-time. Specific serotypes exhibited variable colonization duration, ranging from 17.5 to 100.3 days.
- 23 October 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Proportion of Colonized Person-time With Streptococcus pneumoniae and Duration of Colonization With Individual Serotypes in Young Peruvian Children
Few studies have characterized the proportion of time a child spends with nasopharyngeal pneumococcal colonization, thus at risk for pneumococcal disease. In this prospective study conducted in the early 7-valent pneumococcal conjugate vaccine implementation period, young Peruvian children exhibited pneumococcal colonization during half of the observed person-time. Specific serotypes exhibited variable colonization duration, ranging from 17.5 to 100.3 days.
- 24 February 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (2) , e413-e415
Two for the Price of One: Can Maternal Influenza Immunization Protect Infants Against Influenza and RSV?
Jennifer E Schuster, Leigh M Howard; Two for the price of one: Can maternal influenza immunization protect infants against influenza and RSV?, Clinical Inf
- 24 February 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (2) , e413-e415
Two for the Price of One: Can Maternal Influenza Immunization Protect Infants Against Influenza and RSV?
Jennifer E Schuster, Leigh M Howard; Two for the price of one: Can maternal influenza immunization protect infants against influenza and RSV?, Clinical Inf
- 20 February 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (3) , 140
Post-MIS-C cardiovascular outcomes: a systematic review
Limited knowledge and variability in findings exist regarding the resolution of cardiovascular outcomes following Multisystem Inflammatory Syndrome in Children (MIS-C). We conducted a systematic review to estimate the frequency of cardiovascular outcomes following MIS-C. A systematic search was conducted in Pubmed/Medline, Scopus, Embase, SciELO, LILACS, Cochrane Library, Web of Science, and medRxiv were searched up to February 2024. We included studies reporting cardiovascular events that began in acute MIS-C and persisted after discharge. Screening and data extraction were performed by independent reviewers. We performed a random-effects meta-analysis and assessed the certainty of the evidence using the GRADE approach. Eighty-four studies (n = 4,778) were included; seven had a comparator group. The frequency of cardiovascular outcomes—including coronary abnormalities (Z-score ≥ 2), left ventricle ejection fraction < 55%, diastolic dysfunction, myocarditis, and pericardial effusion—decreased over time, with most resolving by 6 to 9 months. However, cardiac magnetic resonance imaging studies identified myocardial edema and/or fibrosis persisting up to 12 months, and two studies reported coronary abnormalities at 18- to 24-month follow-up. Evidence certainty was very low. Compared to children with COVID-19 or healthy controls, MIS-C showed more cardiovascular events and greater subclinical myocardial dysfunction, as assessed by strain analysis, during a 6-month follow-up. Compared with other etiologies of myocarditis, MIS-C myocarditis was associated with better cardiovascular outcomes but shorter exercise duration and lower aerobic capacity on stress testing. Conclusions: Cardiovascular outcomes following MIS-C improved over time, but certain subclinical cardiac abnormalities persisted up to 12 to 24 months. These findings may support long-term follow-up after MIS-C. Trial registration: Protocol registration number: PROSPERO, CRD42022336784. What is Known: • Multisystem Inflammatory Syndrome in Children (MIS-C) may lead to persistent cardiovascular complications. However, studies show variability in their findings, with heterogeneous follow-up durations—including limited long-term data—small sample sizes, and data mostly originating from single-center experiences in high-income countries. What is New: • Cardiovascular outcomes following MIS-C improved over time across global reports, most resolving by 6–9 months; however, advanced non-invasive methods have identified subclinical cardiac abnormalities up to 12–24 months. This may support the development of evidence-based follow-up recommendations after MIS-C.
- 20 February 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (3) , 140
Post-MIS-C cardiovascular outcomes: a systematic review
Limited knowledge and variability in findings exist regarding the resolution of cardiovascular outcomes following Multisystem Inflammatory Syndrome in Children (MIS-C). We conducted a systematic review to estimate the frequency of cardiovascular outcomes following MIS-C. A systematic search was conducted in Pubmed/Medline, Scopus, Embase, SciELO, LILACS, Cochrane Library, Web of Science, and medRxiv were searched up to February 2024. We included studies reporting cardiovascular events that began in acute MIS-C and persisted after discharge. Screening and data extraction were performed by independent reviewers. We performed a random-effects meta-analysis and assessed the certainty of the evidence using the GRADE approach. Eighty-four studies (n = 4,778) were included; seven had a comparator group. The frequency of cardiovascular outcomes—including coronary abnormalities (Z-score ≥ 2), left ventricle ejection fraction < 55%, diastolic dysfunction, myocarditis, and pericardial effusion—decreased over time, with most resolving by 6 to 9 months. However, cardiac magnetic resonance imaging studies identified myocardial edema and/or fibrosis persisting up to 12 months, and two studies reported coronary abnormalities at 18- to 24-month follow-up. Evidence certainty was very low. Compared to children with COVID-19 or healthy controls, MIS-C showed more cardiovascular events and greater subclinical myocardial dysfunction, as assessed by strain analysis, during a 6-month follow-up. Compared with other etiologies of myocarditis, MIS-C myocarditis was associated with better cardiovascular outcomes but shorter exercise duration and lower aerobic capacity on stress testing. Conclusions: Cardiovascular outcomes following MIS-C improved over time, but certain subclinical cardiac abnormalities persisted up to 12 to 24 months. These findings may support long-term follow-up after MIS-C. Trial registration: Protocol registration number: PROSPERO, CRD42022336784. What is Known: • Multisystem Inflammatory Syndrome in Children (MIS-C) may lead to persistent cardiovascular complications. However, studies show variability in their findings, with heterogeneous follow-up durations—including limited long-term data—small sample sizes, and data mostly originating from single-center experiences in high-income countries. What is New: • Cardiovascular outcomes following MIS-C improved over time across global reports, most resolving by 6–9 months; however, advanced non-invasive methods have identified subclinical cardiac abnormalities up to 12–24 months. This may support the development of evidence-based follow-up recommendations after MIS-C.
- Open Access
- 4 November 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (11) , e0172725
Epidemiology of respiratory syncytial virus in young, hospitalized children in Jordan: a prospective viral surveillance study
Respiratory syncytial virus (RSV) is a leading cause of hospitalization in young children. Understanding RSV burden and seasonality is crucial for implementing effective preventive strategies, especially in the wake of disruptions related to the coronavirus disease 2019 (COVID-19) pandemic. We aimed to determine RSV burden and seasonality among young children hospitalized in Jordan. We conducted a prospective viral surveillance study at Al-Bashir Hospital (1 November 2023 to 4 April 2024). Children n = 680 [30.0%]). Children with RSV were more likely than those without RSV to receive low-flow oxygen (74.9% vs 23.2%; P < 0.001) and high-flow nasal cannulation (3.2% vs 1.2%; P < 0.001) and were more likely to be admitted to the intensive care unit (13.2% vs 8.2%; P < 0.001). At least one other respiratory virus was co-detected with RSV in 244 children (34.2%). During the 2023–2024 season, RSV circulation exhibited a clear winter seasonality, consistent with historical patterns. In conclusion, the burden of RSV in children in Jordan remains substantial following the COVID-19 pandemic. The return to historical winter seasonality has important implications for the timing of preventive interventions. Continued surveillance is crucial for monitoring RSV epidemiology in this region. IMPORTANCE: This study confirms the persistent and significant burden of respiratory syncytial virus (RSV) among young, hospitalized children in Jordan. Crucially, our data reveal the normalization of RSV circulation patterns in 2024 following disruptions related to the coronavirus disease 2019 pandemic. This finding has important implications for optimizing the timing of preventive interventions, such as monoclonal antibodies and maternal vaccination, particularly in a resource-limited setting where they are costly and limited in availability. By providing these contemporary surveillance data from the Eastern Mediterranean—where sentinel surveillance platforms are lacking—this work has the potential to inform public health strategies directly and emphasizes the critical need for sustained monitoring to guide effective RSV prevention and control efforts.
- 4 November 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (11) , e0172725
Open AccessEpidemiology of respiratory syncytial virus in young, hospitalized children in Jordan: a prospective viral surveillance study
Respiratory syncytial virus (RSV) is a leading cause of hospitalization in young children. Understanding RSV burden and seasonality is crucial for implementing effective preventive strategies, especially in the wake of disruptions related to the coronavirus disease 2019 (COVID-19) pandemic. We aimed to determine RSV burden and seasonality among young children hospitalized in Jordan. We conducted a prospective viral surveillance study at Al-Bashir Hospital (1 November 2023 to 4 April 2024). Children n = 680 [30.0%]). Children with RSV were more likely than those without RSV to receive low-flow oxygen (74.9% vs 23.2%; P < 0.001) and high-flow nasal cannulation (3.2% vs 1.2%; P < 0.001) and were more likely to be admitted to the intensive care unit (13.2% vs 8.2%; P < 0.001). At least one other respiratory virus was co-detected with RSV in 244 children (34.2%). During the 2023–2024 season, RSV circulation exhibited a clear winter seasonality, consistent with historical patterns. In conclusion, the burden of RSV in children in Jordan remains substantial following the COVID-19 pandemic. The return to historical winter seasonality has important implications for the timing of preventive interventions. Continued surveillance is crucial for monitoring RSV epidemiology in this region. IMPORTANCE: This study confirms the persistent and significant burden of respiratory syncytial virus (RSV) among young, hospitalized children in Jordan. Crucially, our data reveal the normalization of RSV circulation patterns in 2024 following disruptions related to the coronavirus disease 2019 pandemic. This finding has important implications for optimizing the timing of preventive interventions, such as monoclonal antibodies and maternal vaccination, particularly in a resource-limited setting where they are costly and limited in availability. By providing these contemporary surveillance data from the Eastern Mediterranean—where sentinel surveillance platforms are lacking—this work has the potential to inform public health strategies directly and emphasizes the critical need for sustained monitoring to guide effective RSV prevention and control efforts.
- Open Access
- 1 April 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (4) , e0269124
Antibiotic use among young, hospitalized children in Jordan, 2010–2023
Inappropriate antibiotic use drives antimicrobial resistance, a global health threat causing increased morbidity and mortality. Understanding antibiotic practices in low-resource settings is essential to identify intervention targets. This study investigates antibiotic prescription practices in Amman, Jordan. We conducted three prospective viral surveillance studies at the largest public hospital in Amman, Jordan (2010–2013, 2020, and 2023) and included children Watch group. One or more respiratory viruses were detected in 3,911 children (82.8%). Providers ordered cultures most often for children 0–2 months old ( n = 1,579 [73.5%]) and those with an admission diagnosis of rule-out sepsis ( n = 1,164 [95.4%]). Antibiotic use and testing practices were consistent across study years, age groups, and admission diagnoses. In conclusion, widespread antibiotic use despite the preponderance of viral infections highlights a significant discrepancy in aligning treatment practices with disease etiology. Strengthening diagnostic and preventive capabilities in low-resource settings is crucial to combat antimicrobial resistance. IMPORTANCE: In this study of 4,724 children under 2 years old hospitalized in the largest public hospital in Jordan between 2010 and 2023, 92.6% received antibiotics despite 82.8% testing positive for respiratory viruses and only 13.9% of collected cultures suggesting bacterial infection. Despite the predominance of viral infections, the widespread use of antibiotics, particularly from the World Health Organization Watch group, highlights the need for improved antibiotic stewardship and diagnostic capabilities in Jordan.
- 1 April 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (4) , e0269124
Open AccessAntibiotic use among young, hospitalized children in Jordan, 2010–2023
Inappropriate antibiotic use drives antimicrobial resistance, a global health threat causing increased morbidity and mortality. Understanding antibiotic practices in low-resource settings is essential to identify intervention targets. This study investigates antibiotic prescription practices in Amman, Jordan. We conducted three prospective viral surveillance studies at the largest public hospital in Amman, Jordan (2010–2013, 2020, and 2023) and included children Watch group. One or more respiratory viruses were detected in 3,911 children (82.8%). Providers ordered cultures most often for children 0–2 months old ( n = 1,579 [73.5%]) and those with an admission diagnosis of rule-out sepsis ( n = 1,164 [95.4%]). Antibiotic use and testing practices were consistent across study years, age groups, and admission diagnoses. In conclusion, widespread antibiotic use despite the preponderance of viral infections highlights a significant discrepancy in aligning treatment practices with disease etiology. Strengthening diagnostic and preventive capabilities in low-resource settings is crucial to combat antimicrobial resistance. IMPORTANCE: In this study of 4,724 children under 2 years old hospitalized in the largest public hospital in Jordan between 2010 and 2023, 92.6% received antibiotics despite 82.8% testing positive for respiratory viruses and only 13.9% of collected cultures suggesting bacterial infection. Despite the predominance of viral infections, the widespread use of antibiotics, particularly from the World Health Organization Watch group, highlights the need for improved antibiotic stewardship and diagnostic capabilities in Jordan.
- Open Access
- 20 March 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (4) , ofaf157
Pandemic Social Distancing and Declines in Nasopharyngeal Carriage of Pneumococcus and Related Antimicrobial-Resistant Genes: Evidence From Household-Based Cohort Studies in Lima, Peru
Background: Peru implemented restrictive social distancing policies during the COVID-19 pandemic. Few studies have examined patterns of nasopharyngeal pneumococcal carriage and related antimicrobial-resistant genes (ARGs), particularly in community-based settings with intense social distancing policies. Methods: Nasopharyngeal swabs were systematically obtained weekly from children and adults enrolled in 2 household-based prospective cohorts in Lima, Peru: prepandemic (2019–2020) and pandemic (2020–2021). Selected samples underwent sequencing-based detection of Streptococcus pneumoniae and related ARGs. We compared detections of pneumococcus and erm genes between cohorts during the same 7 epidemiologic weeks in 2020 and 2021 while accounting for relevant covariates and household clustering by mixed effects logistic regression models. Results: An overall 663 specimens from 114 individuals were included: 407 and 256 samples from the prepandemic and pandemic cohorts, respectively. Carriage of pneumococcus was lower in the pandemic cohort (3.5%) as compared with the prepandemic cohort (23.6%; adjusted odds ratio, 0.09; 95% CI, .02–.32). Similarly, erm gene carriage was lower in the pandemic cohort (28.1%) as compared with the prepandemic cohort (58.7%; adjusted odds ratio, 0.21; 95% CI, .10–.46). Conclusions: We observed a substantial reduction in the carriage of S pneumoniae and related ARGs in community-dwelling individuals during a pandemic period with intense social distancing in Lima, Peru.
- 20 March 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (4) , ofaf157
Open AccessPandemic Social Distancing and Declines in Nasopharyngeal Carriage of Pneumococcus and Related Antimicrobial-Resistant Genes: Evidence From Household-Based Cohort Studies in Lima, Peru
Background: Peru implemented restrictive social distancing policies during the COVID-19 pandemic. Few studies have examined patterns of nasopharyngeal pneumococcal carriage and related antimicrobial-resistant genes (ARGs), particularly in community-based settings with intense social distancing policies. Methods: Nasopharyngeal swabs were systematically obtained weekly from children and adults enrolled in 2 household-based prospective cohorts in Lima, Peru: prepandemic (2019–2020) and pandemic (2020–2021). Selected samples underwent sequencing-based detection of Streptococcus pneumoniae and related ARGs. We compared detections of pneumococcus and erm genes between cohorts during the same 7 epidemiologic weeks in 2020 and 2021 while accounting for relevant covariates and household clustering by mixed effects logistic regression models. Results: An overall 663 specimens from 114 individuals were included: 407 and 256 samples from the prepandemic and pandemic cohorts, respectively. Carriage of pneumococcus was lower in the pandemic cohort (3.5%) as compared with the prepandemic cohort (23.6%; adjusted odds ratio, 0.09; 95% CI, .02–.32). Similarly, erm gene carriage was lower in the pandemic cohort (28.1%) as compared with the prepandemic cohort (58.7%; adjusted odds ratio, 0.21; 95% CI, .10–.46). Conclusions: We observed a substantial reduction in the carriage of S pneumoniae and related ARGs in community-dwelling individuals during a pandemic period with intense social distancing in Lima, Peru.
- 24 June 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (12) , e467
Two Pediatric Cases of Left-sided, Native-valve Streptococcus pneumoniae Endocarditis
- 24 June 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (12) , e467
Two Pediatric Cases of Left-sided, Native-valve Streptococcus pneumoniae Endocarditis
- 4 March 2024
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 37 (3) , 170-175
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children
Purpose of review: Prevention of acute respiratory illnesses (ARI) in children is a global health priority, as these remain a leading cause of pediatric morbidity and mortality throughout the world. As new products and strategies to prevent respiratory infections caused by important pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, respiratory syncytial virus and pneumococcus are advancing, increasing evidence suggests that these and other respiratory viruses and pneumococci may exhibit interactions that are associated with altered colonization and disease dynamics. We aim to review recent data evaluating interactions between respiratory viruses and pneumococci in the upper respiratory tract and their potential impact on pneumococcal colonization patterns and disease outcomes. Recent findings: While interactions between influenza infection and subsequent increased susceptibility and transmissibility of colonizing pneumococci have been widely reported in the literature, emerging evidence suggests that human rhinovirus, SARS-CoV-2, and other viruses may also exhibit interactions with pneumococci and alter pneumococcal colonization patterns. Additionally, colonizing pneumococci may play a role in modifying outcomes associated with respiratory viral infections. Recent evidence suggests that vaccination with pneumococcal conjugate vaccines, and prevention of colonization with pneumococcal serotypes included in these vaccines, may be associated with reducing the risk of subsequent viral infection and the severity of the associated illnesses. Summary: Understanding the direction and dynamics of viral-pneumococcal interactions may elucidate the potential effects of existing and emerging viral and bacterial vaccines and other preventive strategies on the health impact of these important respiratory pathogens.
- 4 March 2024
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 37 (3) , 170-175
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children
Purpose of review: Prevention of acute respiratory illnesses (ARI) in children is a global health priority, as these remain a leading cause of pediatric morbidity and mortality throughout the world. As new products and strategies to prevent respiratory infections caused by important pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, respiratory syncytial virus and pneumococcus are advancing, increasing evidence suggests that these and other respiratory viruses and pneumococci may exhibit interactions that are associated with altered colonization and disease dynamics. We aim to review recent data evaluating interactions between respiratory viruses and pneumococci in the upper respiratory tract and their potential impact on pneumococcal colonization patterns and disease outcomes. Recent findings: While interactions between influenza infection and subsequent increased susceptibility and transmissibility of colonizing pneumococci have been widely reported in the literature, emerging evidence suggests that human rhinovirus, SARS-CoV-2, and other viruses may also exhibit interactions with pneumococci and alter pneumococcal colonization patterns. Additionally, colonizing pneumococci may play a role in modifying outcomes associated with respiratory viral infections. Recent evidence suggests that vaccination with pneumococcal conjugate vaccines, and prevention of colonization with pneumococcal serotypes included in these vaccines, may be associated with reducing the risk of subsequent viral infection and the severity of the associated illnesses. Summary: Understanding the direction and dynamics of viral-pneumococcal interactions may elucidate the potential effects of existing and emerging viral and bacterial vaccines and other preventive strategies on the health impact of these important respiratory pathogens.
- 5 January 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (3) , 716-725
Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients
Background: Avian influenza viruses pose significant risk to human health. Vaccines targeting the hemagglutinin of these viruses are poorly immunogenic without the use of adjuvants. Methods: Twenty healthy men and women (18–49 years of age) were randomized to receive 2 doses of inactivated influenza A/H5N1 vaccine alone (IIV) or with AS03 adjuvant (IIV-AS03) 1 month apart. Urine and serum samples were collected on day 0 and on days 1, 3, and 7 following first vaccination and subjected to metabolomics analyses to identify metabolites, metabolic pathways, and metabolite clusters associated with immunization. Results: Seventy-three differentially abundant (DA) serum and 88 urine metabolites were identified for any postvaccination day comparison. Pathway analysis revealed enrichment of tryptophan, tyrosine, and nicotinate metabolism in urine and serum among IIV-AS03 recipients. Increased urine abundance of 4-vinylphenol sulfate on day 1 was associated with serologic response based on hemagglutination inhibition responses. In addition, 9 DA urine metabolites were identified in participants with malaise compared to those without. Conclusions: Our findings suggest that tryptophan, tyrosine, and nicotinate metabolism are upregulated among IIV-AS03 recipients compared with IIV alone. Metabolites within these pathways may serve as measures of immunogenicity and may provide mechanistic insights for adjuvanted vaccines. Clinical Trials Registration: NCT01573312.
- 5 January 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (3) , 716-725
Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients
Background: Avian influenza viruses pose significant risk to human health. Vaccines targeting the hemagglutinin of these viruses are poorly immunogenic without the use of adjuvants. Methods: Twenty healthy men and women (18–49 years of age) were randomized to receive 2 doses of inactivated influenza A/H5N1 vaccine alone (IIV) or with AS03 adjuvant (IIV-AS03) 1 month apart. Urine and serum samples were collected on day 0 and on days 1, 3, and 7 following first vaccination and subjected to metabolomics analyses to identify metabolites, metabolic pathways, and metabolite clusters associated with immunization. Results: Seventy-three differentially abundant (DA) serum and 88 urine metabolites were identified for any postvaccination day comparison. Pathway analysis revealed enrichment of tryptophan, tyrosine, and nicotinate metabolism in urine and serum among IIV-AS03 recipients. Increased urine abundance of 4-vinylphenol sulfate on day 1 was associated with serologic response based on hemagglutination inhibition responses. In addition, 9 DA urine metabolites were identified in participants with malaise compared to those without. Conclusions: Our findings suggest that tryptophan, tyrosine, and nicotinate metabolism are upregulated among IIV-AS03 recipients compared with IIV alone. Metabolites within these pathways may serve as measures of immunogenicity and may provide mechanistic insights for adjuvanted vaccines. Clinical Trials Registration: NCT01573312.
- Open Access
- 13 July 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 134, 248-255
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
- 13 July 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 134, 248-255
Open AccessAssociation between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children